Arthritis, Rheumatoid: all 2,962 studies

Page 6 of 30. Open to participants first (396), then studies with results posted, then the rest; newest registration first within each.

• Safety and Tolerability Study Of PF-06835375 In Subjects With Seropositive Systemic Lupus Erythematosus Or Rheumatoid ArthritisCompletedNCT03334851Phase 1Results posted
• Lipopolysaccharide (LPS) or Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Challenge Study on Healthy SubjectsCompletedNCT03306589Phase 1Results posted
• INFINITY™Total Ankle Replacement Follow-upTerminatedNCT03277989Results posted
• Long Term Follow-up of Integra® Cadence™ Total Ankle System in Primary Ankle Joint ReplacementTerminatedNCT03247023Results posted
• Phase IIb Study of Evobrutinib in Subjects With Rheumatoid ArthritisCompletedNCT03233230Phase 2Results posted
• Study to Demonstrate Non-Inferior Efficacy and Safety of CinnoRA® Versus Humira® for Treatment of Active RACompletedNCT03172325Phase 3Results posted
• Multiple Ascending Doses of Rozibafusp Alfa (AMG 570) in Adults With Rheumatoid ArthritisCompletedNCT03156023Phase 1Results posted
• A Phase I/III Study to Evaluate Efficacy, PK and Safety Between CT-P13 SC and CT-P13 IV in Patients With Active RACompletedNCT03147248Phase 3Results posted
• Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid ArthritisCompletedNCT03120949Phase 3Results posted
• A Phase 3 Study to Compare Upadacitinib to Abatacept in Subjects With Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease- Modifying Antirheumatic Drugs (csDMARDs) Who Have an Inadequate Response or Intolerance to Biologic DMARDsCompletedNCT03086343Phase 3Results posted
• Patient-Reported Outcomes In Rheumatoid Arthritis Patients Treated With Tofacitinib Or Biological Disease-Modifying Antirheumatic Drugs (DMARDs) In Real Life ConditionsCompletedNCT03073109Results posted
• MSB11022 in Moderate to Severe Rheumatoid ArthritisCompletedNCT03052322Phase 3Results posted
• Evaluation of Pharmacokinetics and Safety of GSK3196165 in Combination With Methotrexate in Japanese Subjects With Rheumatoid ArthritisCompletedNCT03028467Phase 1/2Results posted
• Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid ArthritisCompletedNCT03025308Phase 3Results posted
• Low Dose Naltrexone for Chronic Pain From ArthritisCompletedNCT03008590Phase 2Results posted
• A Study of RO7123520 to Evaluate the Safety and Efficacy in Participants With Moderately To Severely Active Rheumatoid Arthritis (RA) Who Are Inadequately Responding to Anti-Tumor Necrosis Factor (TNF)-Alpha TherapyTerminatedNCT03001219Phase 2Results posted
• Safety and Efficacy of Pf-06650833 In Subjects With Rheumatoid Arthritis, With An Inadequate Response To MethotrexateCompletedNCT02996500Phase 2Results posted
• A Phase 3 Study of NI-071 in Participants With Rheumatoid Arthritis (RADIANCE)CompletedNCT02990806Phase 3Results posted
• Study to Assess the Injection Site Pain Associated With a New Etanercept Formulation in Adults With Rheumatoid Arthritis or Psoriatic ArthritisCompletedNCT02986139Phase 3Results posted
• The Effects of Hyperbaric Oxygen on Rheumatoid ArthritisCompletedNCT02984943Not applicableResults posted
• Korean Post-marketing Surveillance for XeljanzCompletedNCT02984020Results posted
• A Study to Evaluate the Long-Term Safety and Efficacy of GDC-0853 in Participants With Moderate to Severe Rheumatoid Arthritis Enrolled in Study GA29350CompletedNCT02983227Phase 2Results posted
• Study To Assess The Efficacy And Safety Of Pf-06651600 In Subjects With Rheumatoid Arthritis With An Inadequate Response To MethotrexateCompletedNCT02969044Phase 2Results posted
• Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK3117391 in Subjects With Rheumatoid ArthritisTerminatedNCT02965599Phase 2Results posted
• A Phase 2 Study of E6011 in Subjects With Rheumatoid Arthritis Inadequately Responding to BiologicsCompletedNCT02960490Phase 2Results posted
• A Dose Response Study of E6011 in Participants With Rheumatoid Arthritis Inadequately Responding to MethotrexateCompletedNCT02960438Phase 2Results posted
• Clinical Follow-up of Anti-Carbamylated Antibody Status in Rheumatoid ArthritisCompletedNCT02958319Results posted
• A Study With Upadacitinib (ABT-494) in Subjects From China and Selected Countries With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs)CompletedNCT02955212Phase 3Results posted
• Study to Assess if ABP710 is Safe & Effective in Treating Moderate to Severe Rheumatoid Arthritis Compared to InfliximabCompletedNCT02937701Phase 3Results posted
• Standard Versus High Dose Inactivated Influenza Vaccine in RACompletedNCT02936180Phase 4Results posted
• Comparison of Disease Modifying Antirheumatic Drugs Therapy in Patients With RA Failing Methotrexate MonotherapyTerminatedNCT02930343Phase 3Results posted
• Safety and Effectiveness of Acthar Gel in Participants With Rheumatoid ArthritisCompletedNCT02919761Phase 4Results posted
• Study to Evaluate Efficacy, Safety and Tolerability of JTE-051 in Subjects With Active Rheumatoid ArthritisCompletedNCT02919475Phase 2Results posted
• Does Sildenafil Improve Endothelial Dysfunction in Rheumatoid Arthritis?TerminatedNCT02908490Phase 2Results posted
• Filgotinib in Combination With Methotrexate in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to MethotrexateCompletedNCT02889796Phase 3Results posted
• Filgotinib Alone and in Combination With Methotrexate (MTX) in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Are Naive to MTX TherapyCompletedNCT02886728Phase 3Results posted
• Safety, Tolerability, and Efficacy of GS-9876 in Participants With Active Rheumatoid Arthritis on Background Therapy With MethotrexateCompletedNCT02885181Phase 2Results posted
• Ticagrelor in Methotrexate-Resistant Rheumatoid ArthritisCompletedNCT02874092Phase 4Results posted
• Filgotinib Versus Placebo in Adults With Active Rheumatoid Arthritis (RA) Who Have an Inadequate Response to Biologic Disease-modifying Anti-rheumatic Drug(s) (DMARDs) TreatmentCompletedNCT02873936Phase 3Results posted
• Evaluating Safety of Escalating Doses of Tilmanocept by IV Injection and SPECT Imaging in Subjects With and Without RACompletedNCT02865434Phase 1/2Results posted
• Andecaliximab as Add-On Therapy to a Tumor Necrosis Factor Inhibitor and Methotrexate Regimen in Adults With Moderately to Severely Active Rheumatoid ArthritisTerminatedNCT02862574Phase 2Results posted
• Safety and Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy of Repeat Doses of GSK2982772 in Subjects With Moderate to Severe Rheumatoid Arthritis (RA)CompletedNCT02858492Phase 2Results posted
• Safety and Efficacy Study of GDC-0853 Compared With Placebo and Adalimumab in Participants With Rheumatoid Arthritis (RA)CompletedNCT02833350Phase 2Results posted
• Methotrexate Withdrawal Study of Tofacitinib Modified Release Formulation in Subjects With Rheumatoid ArthritisCompletedNCT02831855Phase 4Results posted
• Enhancing Patient Ability to Understand and Utilize Complex Information Concerning Medication Self-managementCompletedNCT02820038Not applicableResults posted
• PK, PD, Safety, and Efficacy of SAIT101 Versus MabThera® Versus Rituxan® in Patients With Rheumatoid ArthritisCompletedNCT02819726Phase 1Results posted
• Use of Tocilizumab for Rheumatoid Arthritis (RA) in Daily RoutineCompletedNCT02809833Results posted
• Phase ll Study of Pirfenidone in Patients With RAILD (TRAIL1)CompletedNCT02808871Phase 2Results posted
• Mechanistic Study of GSK3196165 Plus Methotrexate (MTX) in Subjects With Active Rheumatoid ArthritisCompletedNCT02799472Phase 2Results posted
• Study to Assess if ABP 798 is Safe & Effective in Treating Moderate to Severe Rheumatoid Arthritis (RA) Compared to RituximabCompletedNCT02792699Phase 3Results posted
• Safety and Efficacy Study of M2951 in Participants With Rheumatoid ArthritisCompletedNCT02784106Phase 2Results posted
• Actis Total Hip System 2 Year Follow-upCompletedNCT02783274Not applicableResults posted
• A Phase 1b Study of MEDI4920 in Participants With Adult-onset Rheumatoid ArthritisCompletedNCT02780388Phase 1Results posted
• Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo, in Subjects With Rheumatoid Arthritis (RA) Who Were Taking an Existing Medication Called a Tumour Necrosis Factor Alpha Inhibitor But Had Active DiseaseCompletedNCT02760433Phase 3Results posted
• Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo and Adalimumab, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active DiseaseCompletedNCT02760407Phase 3Results posted
• Evaluation of the Effectiveness and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active DiseaseCompletedNCT02760368Phase 3Results posted
• Post-marketing Observational Study to Evaluate the Incremental Impact of AbbVie's Patient Support Program on Patient Reported Outcomes and Health Resource Utilization in Inflammatory Arthritis, Psoriasis and Inflammatory Bowel Diseases in Hungary (VALUE)CompletedNCT02750800Results posted
• MTX Discontinuation and Vaccine ResponseCompletedNCT02748785Phase 4Results posted
• Clinical Trial to Compare Treatment With GP2017 and Humira® in Patients With Rheumatoid ArthritisCompletedNCT02744755Phase 3Results posted
• Usability of an AI for M923 in Subjects With Moderate to Severe RACompletedNCT02722044Phase 3Results posted
• A Study to Compare Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis (RA) Who Are on a Stable Dose of Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs) and Have an Inadequate Response to csDMARDsCompletedNCT02720523Phase 2/3Results posted
• Lipids, Inflammation, and CV Risk in RACompletedNCT02714881Results posted
• A Study Comparing Upadacitinib (ABT-494) Monotherapy to Methotrexate (MTX) Monotherapy in Adults With Rheumatoid Arthritis (RA) Who Have an Inadequate Response to MTX (SELECT-MONOTHERAPY)CompletedNCT02706951Phase 3Results posted
• A Study to Compare Upadacitinib (ABT-494) Monotherapy to Methotrexate (MTX) Monotherapy in Adults With Rheumatoid Arthritis (RA) Who Have Not Previously Taken MethotrexateCompletedNCT02706873Phase 3Results posted
• A Study to Compare Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) With an Inadequate Response or Intolerance to Biologic DMARDsCompletedNCT02706847Phase 3Results posted
• Study to Examine Efficacy and Safety of Rituximab in Participants With Rheumatoid ArthritisCompletedNCT02699892Results posted
• Evaluation of SC Injected Tc 99m Tilmanocept Localization in Active RA Subjects by SPECT and SPECT/CT ImagingCompletedNCT02683421Phase 1Results posted
• Tocilizumab Real-Life Human Factors (RLHFs) Validation StudyCompletedNCT02682823Phase 4Results posted
• A Study Comparing Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis on a Stable Dose of Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) Who Have an Inadequate Response to csDMARDs AloneCompletedNCT02675426Phase 3Results posted
• Real-World Outcome of Adalimumab on Rheumatoid Arthritis Patients in ChinaCompletedNCT02668640Results posted
• Effect of Subcutaneous ACTEMRA on Inflamed Atherosclerotic Plaques in Patients With Rheumatoid ArthritisTerminatedNCT02659150Phase 4Results posted
• Long-term Assessment of Safety and Efficacy of BI 695501 in Patients With Rheumatoid ArthritisCompletedNCT02640612Phase 3Results posted
• Efficacy and Safety Study of BMS-986142 in Patients With Moderate to Severe Rheumatoid ArthritisCompletedNCT02638948Phase 2Results posted
• Comparative Efficacy and Safety Study of GP2015 and Enbrel® in Patients With Rheumatoid ArthritisCompletedNCT02638259Phase 3Results posted
• Assessment of the Handling Experience With the BI 695501 Autoinjector in Patients With Rheumatoid Arthritis Followed by an Extension Phase Using BI 695501 Prefilled SyringeCompletedNCT02636907Phase 2Results posted
• A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Adults With Rheumatoid Arthritis Who Are on a Stable Dose of Methotrexate and Who Have an Inadequate Response to MethotrexateActive, not recruitingNCT02629159Phase 3Results posted
• A Study of LY3337641 in Rheumatoid ArthritisTerminatedNCT02628028Phase 2Results posted
• Real-World Outcome of Rheumatoid Arthritis Patients in Korea on AdalimumabCompletedNCT02627924Results posted
• Study to Evaluate Safety and Pharmacokinetics of GS-4059 (Tirabrutinib) in Healthy Volunteers and Participants With Rheumatoid Arthritis (RA)CompletedNCT02626026Phase 1Results posted
• Real-World Outcome of Adalimumab on Rheumatoid Arthritis Patients in TaiwanCompletedNCT02616380Results posted
• Strategy to Prevent the Onset of Clinically-Apparent Rheumatoid ArthritisTerminatedNCT02603146Phase 2Results posted
• An Observational Study to Describe in Routine Clinical Practice the Treatment Patterns of Usage of Biological DMARDs in RA Patients.CompletedNCT02590562Results posted
• The Glucocorticoid Low-dose Outcome in RheumatoId Arthritis StudyCompletedNCT02585258Phase 4Results posted
• Study to Compare the Efficacy of Tocilizumab With or Without Glucocorticoid Discontinuation in Rheumatoid Arthritis ParticipantsCompletedNCT02573012Phase 4Results posted
• An Multicentre Clinical Study to Evaluate the Usability and Safety of the Pre-filled Pen and Pre-filled Syringe of SB5 in Subjects With Rheumatoid ArthritisCompletedNCT02565810Phase 2Results posted
• An Observational Study to Evaluate Safety and Efficacy of Remsima™ in Patients With RATerminatedNCT02557295Results posted
• Study to Assess Changes in the Immune Profile in Adults With Early Rheumatoid ArthritisCompletedNCT02557100Phase 4Results posted
• Use of Acthar in Rheumatoid Arthritis (RA) Related FlaresCompletedNCT02541955Phase 4Results posted
• To Evaluate The Efficacy And Safety Of Sunpharma1505 Compared With Reference1505 In Subjects With Active Rheumatoid ArthritisTerminatedNCT02534896Phase 3Results posted
• Blood Sample Collection Study for Pharmacogenomic Characterization of Participants That Previously Received Namilumab in M1-1188-002-EM (PRIORA, [NCT01317797]) StudyCompletedNCT02528786Phase 1Results posted
• Efficacy and Safety of Buprenorphine Transdermal Patch in Non-cancer Pain of Moderate IntensityCompletedNCT02519387Phase 4Results posted
• An Open-Label Extension Study Assessing the Long-Term Efficacy and Safety of ALX-0061 in Subjects With Rheumatoid ArthritisCompletedNCT02518620Phase 2Results posted
• GP2013 Treatment in Patients With Active Rheumatoid Arthritis, Previously Treated With Rituxan® or MabThera®CompletedNCT02514772Phase 3Results posted
• A Single Ascending Dose Study To Assess The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of AZD9567.CompletedNCT02512575Phase 1Results posted
• An Observational Quality of Life Study in Participants With Rheumatoid Arthritis Treated With RituximabCompletedNCT02507752Results posted
• Study to Evaluate the Efficacy and Safety of GSK3196165 Plus Methotrexate in Subjects With Active Moderate-Severe Rheumatoid ArthritisCompletedNCT02504671Phase 2Results posted
• Effects of Abatacept in Patients With Early Rheumatoid ArthritisCompletedNCT02504268Phase 3Results posted
• A Study To Evaluate The Efficacy Of Enbrel (REGISTERED) Etanercept Over A Period Of 12 Months In The Routine Treatment Of Patients With Rheumatoid Arthritis, Axial Spondyloarthritis, Psoriatic Arthritis, Or Plaque Psoriasis.CompletedNCT02486302Results posted
• Study for Validation of Standardized Questionnaires on Depression and Investigation of the Frequency of Depression in Rheumatoid Arthritis (RA) ParticipantsCompletedNCT02485483Results posted
• A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira®) In Combination With Methotrexate In Subjects With Active Rheumatoid Arthritis (REFLECTIONS B538-02).CompletedNCT02480153Phase 3Results posted

← Arthritis, Rheumatoid overview